TABLE 3.
Baseline Patient‐Reported Outcomes in the Active Surveillance and Systemic Therapy Cohorts
| Initial Treatment Assignment | AS, n = 143 | ST, n = 305 | P |
|---|---|---|---|
| NCCN‐FACT FKSI‐19 score, no. | 120 | 239 | |
| Median (IQR: 25%, 75%) | 59 (55, 65) | 55 (46, 63) | <.0001 |
| FACT‐G score, no. | 120 | 239 | |
| Median (IQR: 25%, 75%) | 88 (76, 98) | 79 (64, 92) | <.0001 |
| Physical well‐being (IQR: 25%, 75%) | 25 (23, 27) | 23 (18, 26) | .0001 |
| Social well‐being (IQR: 25%, 75%) | 26 (22, 28) | 25 (21, 27) | .1050 |
| Emotional well‐being (IQR: 25%, 75%) | 19 (15, 21) | 17 (13, 20) | .0062 |
| Functional well‐being (IQR: 25%, 75%) | 21 (16, 26) | 17 (11, 23) | <.0001 |
Abbreviations: AS, active surveillance; FACT‐G, Functional Assessment of Cancer Therapy–General; IQR, interquartile range; NCCN‐FACT FKSI‐19, National Comprehensive Cancer Network–Functional Assessment of Cancer Therapy Kidney Symptom Index 19; ST, systemic therapy.